PGR and metastatic malignant neoplasm in the lymph nodes: Large tumor size (pT2-4), presence of lymph node metastasis (pN1-3), and lack of expression of PR were significant predictors of poor prognosis, i.e. short DFS in the set of hormonal therapy-treated patients (p = 0.001, p<0.001, and p = 0.031, respectively).